DRUG

Cannabidiol

3 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Cannabidiol

Glioblastoma 3

Mediator Outcome Score Tier Lit. status Trial
P-glycoprotein multidrug resistance 0.208 Mid reproduces known none
P-glycoprotein multidrug resistance 0.208 Mid reproduces known none
P-glycoprotein temozolomide resistance 0.208 Mid novel signal none

Clinical trials

200 registered trials for Cannabidiol

Source: ClinicalTrials.gov